Differences in clinical outcomes between HER2-negative and HER2-positive luminal B breast cancer

The clinical features and prognosis of breast cancer can vary widely, depending on the molecular subtype. Luminal B breast cancers are usually either estrogen receptor-positive and/or progesterone receptor-positive with high proliferation of Ki67 index, or HER2 positive (HER2+). The authors compared...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Byeongju, Lee, Jeeyeon, Jung, Jin Hyang, Kim, Wan Wook, Keum, Heejung, Park, Ho Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470803/
https://www.ncbi.nlm.nih.gov/pubmed/37653831
http://dx.doi.org/10.1097/MD.0000000000034772

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470803/
https://www.ncbi.nlm.nih.gov/pubmed/37653831
http://dx.doi.org/10.1097/MD.0000000000034772

Ejemplares similares